# FDG-PET/CT in Assessing the Tumor and Planning Neck Surgery in Patients With Newly Diagnosed H&N Cancer

> **NCT00983697** · NA · UNKNOWN · sponsor: **American College of Radiology Imaging Network** · enrollment: 292 (estimated)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **PROCEDURE:** therapeutic conventional surgery
- **RADIATION:** fludeoxyglucose F 18

## Key facts

- **NCT ID:** NCT00983697
- **Lead sponsor:** American College of Radiology Imaging Network
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-04-01
- **Primary completion:** 2019-01-15
- **Final completion:** 2021-12
- **Target enrollment:** 292 (ESTIMATED)
- **Last updated:** 2020-10-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00983697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00983697, "FDG-PET/CT in Assessing the Tumor and Planning Neck Surgery in Patients With Newly Diagnosed H&N Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00983697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*